文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

抗菌药物耐药与HIV感染的关联:系统综述与荟萃分析

The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2021-04-01

该系统综述与荟萃分析检索MEDLINE、EMBASE等数据库,纳入1995至2020年发表的92项研究,评估HIV感染者与抗菌药物耐药(AMR)的关联。结果显示HIV感染者耐甲氧西林金黄色葡萄球菌定植和感染、青霉素敏感性降低的肺炎链球菌感染风险均升高,但大肠埃希菌和肺炎克雷伯菌对第三代头孢菌素耐药风险无统计学显著性。研究质量多为中或低,可能影响结论。

要点

  • HIV感染者耐甲氧西林金黄色葡萄球菌定植风险升高(OR 2.12,95%CI 1.36-3.30)。
  • HIV感染者耐甲氧西林金黄色葡萄球菌感染风险升高(OR 1.90,95%CI 1.45-2.48)。
  • HIV感染者青霉素敏感性降低的肺炎链球菌感染风险升高(OR 2.28,95%CI 1.75-2.97)。

核心结论

  • HIV感染者在多种细菌病原体和多个药物类别中抗菌药物耐药风险升高。
  • HIV负担最重的国家缺乏AMR实验室鉴定能力和替代治疗选择,需更多研究。
  • 纳入研究总体质量为中或低,可能影响本综述的发现。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE、Web of Science、LILACS和African Journals Online。
  • 纳入报告细菌病原体(排除分枝杆菌和引起性传播感染的细菌)定植或感染AMR且按HIV状态、菌种和受试抗菌药物分层的研究,共92项,发表于1995至2020年。

主要发现

  • 纳入研究涉及的菌种包括金黄色葡萄球菌(n=47)、肺炎链球菌(n=28)、大肠埃希菌(n=6)和其他革兰阴性菌。
  • HIV感染者耐甲氧西林金黄色葡萄球菌定植的合并OR为2.12(95%CI 1.36-3.30),感染的合并OR为1.90(95%CI 1.45-2.48)。
  • HIV感染者青霉素敏感性降低的肺炎链球菌感染的合并OR为2.28(95%CI 1.75-2.97)。
  • HIV感染者大肠埃希菌和肺炎克雷伯菌对第三代头孢菌素耐药的合并OR为1.59(95%CI 0.83-3.05)。

临床怎么用

  • 对HIV感染者应关注耐甲氧西林金黄色葡萄球菌和青霉素敏感性降低肺炎链球菌感染的风险,经验性抗菌治疗需考虑耐药可能。

局限性

  • 纳入研究总体质量为中或低,可能影响本综述的发现。
  • HIV负担最重的国家缺乏AMR实验室鉴定能力和替代治疗选择,限制相关研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: People living with HIV (PLWH) are at increased risk of infections with resistant organisms due to more frequent healthcare utilization. Our objective was to investigate the association between HIV and antimicrobial resistance (AMR). METHODS: We searched MEDLINE, EMBASE, Web of Science, LILACS and African Journals Online. Studies were eligible if they reported on AMR for colonization or infection with bacterial pathogens (excluding mycobacteria and bacteria causing sexually transmitted infections) and were stratified by HIV status, species and antimicrobials tested. Pooled odds ratios were used to evaluate the association between HIV and resistance. RESULTS: In total, 92 studies published between 1995 and 2020 were identified. The studies included the following organisms: Staphylococcusaureus (n = 47), Streptococcus pneumoniae (n = 28), Escherichia coli (n = 6) and other Gram-negative bacteria. PLWH had a 2.12 (95%CI 1.36-3.30) higher odds for colonization and 1.90 (95%CI 1.45-2.48) higher odds for infection with methicillin-resistant S. aureus, a 2.28 (95%CI 1.75-2.97) higher odds of infection with S. pneumoniae with decreased penicillin susceptibility, and a 1.59 (95%CI 0.83-3.05) higher odds of resistance to third-generation cephalosporins in E. coli and Klebsiella pneumoniae. CONCLUSION: This review shows an increased risk of AMR in PLWH across a range of bacterial pathogens and multiple drug classes. The lack of laboratory capacity for identifying AMR, and limited access to alternative treatment options in countries with the highest burden of HIV, highlight the need for more research on AMR in PLWH. Overall, the quality of studies was moderate or low, which may impact the findings of this review.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Olaru ID, Tacconelli E, Yeung S, et al. The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2021. PMID: 33813126. doi:10.1016/j.cmi.2021.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。